Our strategy is centred on discovery and validation of new drug targets on a dermatology-specific drug discovery platform called iNeu-3D screen. This is an innovative drug screening platform that combines breakthroughs in cell biology, genetics, computational biology, and molecular biology to acquire a deeper insights of human skin development, disease modelling, and pre-clinical validation of our in-house therapeutic molecules. Our vision is to provide dermatological treatments that are highly efficient, safe, and affordable globally.